BioNationLogin

• Email
  
  Password
  
  
  I've forgotten my password!
  Create an account here!

Gene therapy product might be approved for head and neck cancer treatment

Advexin to be evaluated by regulatory authorities for approval for the treatment of head and neck cancer. by Sandya von der Weid , 20/08/2008

$437 million deal between Genzyme and PTC

Genzyme Corporation and PTC Therapeutics will be collaborating to develop and market the small molecule for genetic disease PTC-124. by Pierre-Philippe Luyet, PhD , 22/07/2008

Neural Stem Cells

In the USA, it is estimated that 1.5 million Americans have Parkinson's disease and 60,000 new cases are diagnosed each year. Moreover, 30,000 Americans suffer from Amyotrophic Lateral Sclerosis, with 5,600 new cases diagnosed each year. Finally, one out of every 10,000 Americans has Huntington's Disease. Concomitantly, these numbers underline why there is a huge potential for treatments. 23/08/2007